Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Zeo ScientifiX (ZEOX) Asset Writedowns and Impairment (2016 - 2023)

Zeo ScientifiX (ZEOX) has 6 years of Asset Writedowns and Impairment data on record, last reported at $13000.0 in Q4 2023.

  • For Q4 2023, Asset Writedowns and Impairment rose 74.38% year-over-year to $13000.0; the TTM value through Oct 2023 reached $84090.0, up 364.84%, while the annual FY2024 figure was $9000.0, 93.66% down from the prior year.
  • Asset Writedowns and Impairment reached $13000.0 in Q4 2023 per ZEOX's latest filing, down from $53000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $53000.0 in Q3 2023 and bottomed at $7455.0 in Q4 2022.
  • Average Asset Writedowns and Impairment over 3 years is $21022.5, with a median of $11817.5 recorded in 2019.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 59.33% in 2019, then soared 74.38% in 2023.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at $10635.0 in 2019, then fell by 29.9% to $7455.0 in 2022, then skyrocketed by 74.38% to $13000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $13000.0 in Q4 2023, $53000.0 in Q3 2023, and $7455.0 in Q4 2022.